Our research relies on an experienced team dedicated to develop breakthrough technological solutions in the field of DNA analysis.

Haploys intends to develop an innovative technological intellectual property portfolio to sustain a leading position in its field and to extend its activities in the field of molecular assistance to medical diagnostics. In the long term, Haploys intends to partner with clinical groups to become a major player in the field of predictive medicine.

We are presently extending the capacity of our technology to allow thousands of DNA samples to be analysed simultaneously and to reduce the costs to outperform DNA chips on large scale studies.

New application fields are being developed too, embracing epigenetics, proteomics, DNA sequencing and re-sequencing and anonymous marker hunting and detection.